Named Patient Program With Rotigotine Transdermal System

Clinical trial NCT01095484 · COMPLETED

Trial details

NCT number: NCT01095484
Sponsor: UCB Pharma
Status: COMPLETED
Study type: OBSERVATIONAL

Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine

Start date: 2008-11-01
Primary completion: 2012-12-01
Enrollment: 520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.